1. Home
  2. SLAB vs PCVX Comparison

SLAB vs PCVX Comparison

Compare SLAB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Laboratories Inc.

SLAB

Silicon Laboratories Inc.

HOLD

Current Price

$220.58

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$61.16

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLAB
PCVX
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.0B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
SLAB
PCVX
Price
$220.58
$61.16
Analyst Decision
Hold
Strong Buy
Analyst Count
11
4
Target Price
$163.13
$88.25
AVG Volume (30 Days)
194.3K
931.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
66.61
N/A
EPS
N/A
N/A
Revenue
$491,625,000.00
N/A
Revenue This Year
$20.49
N/A
Revenue Next Year
$16.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.51
$30.81
52 Week High
$220.90
$65.00

Technical Indicators

Market Signals
Indicator
SLAB
PCVX
Relative Strength Index (RSI) 63.53 55.01
Support Level $216.52 $52.18
Resistance Level $220.61 $63.52
Average True Range (ATR) 0.84 2.28
MACD 0.16 -0.17
Stochastic Oscillator 95.09 52.24

Price Performance

Historical Comparison
SLAB
PCVX

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: